The coming of age of oral methadone maintenance treatment in the UK in the 1990s

Heroin Addiction and The British System

Volumn 2, Issue , 2004, Pages 104-118

  Farrell, Michael ^a   Raistrick, Duncan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84909120891     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203643358     Document Type: Chapter

References (38)

1. ACMD (1982). Treatment and Rehabilitation Report. Department of Health. HMSO, London.
2. ACMD (1993). AIDS and Drug Misuse: An Update. Department of Health. The Stationery Office, London.
3. Buning, E. and van Brussel, G. (1995). The effects of harm reduction in Amsterdam. European Addiction Research, 1, 92-8.
4. Capelhorn, J. (1998). Deaths in the first two weeks of maintenance treatment in New South Wales in 1994: identifying cases of iatrogenic methadone toxicity. Drug and Alcohol Review, 17, 9-18.
5. Department of Health (1999). Drug Misuse and Dependence-Guidelines on Clinical Management, The Stationery Office, London.
6. Farrell, M. and Gerada, C. (1997). Drug misusers: whose business is it? British Medical Journal 315, 559-60.
7. Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G.V., des Jarlais, D., Gossop, M. and Strang, J. (1994). Methadone maintenance treatment in opiate dependence: a review. British Medical Journal 309, 997-1001.
8. Fountain, J. and Strang, J. (2003). The illicit market in methadone: the play, the plot and the players. In G. Tober and J. Strang (eds) Methadone Matters. Dunitz, London.
9. Fountain, J., Griffiths, P., Farrell, M., Gossop, M. and Strang, J. (2000). Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction, 95, 393-406.
10. Gerada, C. and Farrell, M. (1998). Shared care. In R. Robertson (ed.) Treating Drug Misuse in the Community. Routledge, London.
11. Glanz, A., Byrne, C. and Jackson, P. (1989). Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. British Medical Journal 299, 1076-9.
12. Gossop, M., Marsden, J. and Stewart, D. (1998). NTORS at One Year: Changes in Substance Use, Health and Criminal Behaviour One Year after Intake. Department of Health, London.
13. Gossop, M., Marsden, J., Stewart, D. and Rolfe, A. (1999). Treatment retention and one-year outcomes for residential programmes in England. Drug Alcohol Dependence, 57 (2), 89-98.
14. Greenwood, J. (1990). Creating a new drug service in Edinburgh. British Medical Journal, 300, 587-9.
15. Greenwood, J. (1992). Persuading general practitioners to prescribe-good husbandry or a recipe for chaos? British Journal of Addiction, 87:567-75.
16. Gruer, L., Wilson, P., Scott, R., Elliott, L., Macleod, J., Harden, K., Forrester, E., Hinshelwood, S., McNulty, H. and Silk, P. (1997). General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow, British Medical Journal 314, 1730-5.
17. Department of Health (1990). Health of the Nation. HMSO, London.
18. Ling, W., Charavastra, C., Collins, J.F. et al. (1998). Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomised clinical trial, Addiction, 93, 475-86.
19. Luborsky, L., McLellan, A.T., Woody, G.E., O'Brien, C.P. and Auerbach, A. (1985). Therapist success and its determinants. Archives of General Psychiatry, 42, 602-11.
20. MacGregor, S. (1994). Promoting new services: the Central Funding Initiative and other mechanisms. In J. Strang and M. Gossop (eds) Heroin Addiction and Drug Policy: The British System. Oxford: Oxford University Press.
21. McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E. and O'Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment, Journal of the American Medical Association, 269, 1953-9.
22. Metrebian, N., Shanahan, W., Well, S.B. and Stimson, G. (1998). Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Medical Journal of Australia, 168, 596-600.
23. News report (1994). Task force effectiveness of drug services, Druglink, September issue.
24. Prison Service Drug Strategy (1998). Tackling Drugs in Prison. London, HM Prison Service.
25. Raistrick, D. (2003). Psychosocial elements of methadone treatment. In G. Tober and J. Strang (eds) Methadone Matters. Dunitz, London.
26. Robertson, J.R., Ronald, P.J., Raab, J.M., Ross, G.M. and Parpia, T. (1994). Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. British Medical Journal, 309, 369-72.
27. Royal College of Psychiatrists and Physicians (2000). Drugs: Dilemmas and Choices. Gaskell, London.
28. Sheridan, J., Strang, J., Barber, N. and Glanz, A. (1996). Role of community pharmacies in relation to HIV prevention and drug misuse: finding from the 1995 national survey in England and Wales. British Medical Journal, 313:272-4.
29. Sheridan, J., Strang, J., Taylor, C. and Barber, N. (1997). HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training. Addiction, 92, 1737-48.
30. Stimson, G. (1995). AIDS and injecting drug use in the United Kingdom, 1987-1993. The policy response and the prevention of an epidemic. Social Science and Medicine, 41, 699-716.
31. Strang, J. and Sheridan, J. (1998). National and regional characteristics of methadone prescribing in England and Wales: local analyses of data from the 1995 national survey of community pharmacies. Journal of Substance Misuse, 3, 240-6.
32. Strang, J. and Sheridan, J. (2001). Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in south-east England. Addiction, 96, 567-76.
33. Strang, J. and Tober, G. (2003). Methadone: universal panacea or pernicious poison? In G. Tober and J. Strang (eds) Methadone Matters. Dunitz, London.
34. Strang, J., Marsden, J., Cummins, M., Farrell, M., Finch, E., Gossop, M., Stewart, D. and Welch, S. (2000). Randomised trial of supervised injectable versus oral methadone maintenance: report on feasibility and six-month outcome. Addiction, 95:1613-45.
35. Strang, J., Ruben, S., Farrell, M. and Gossop, M. (1994). Prescribing heroin and other injectable drugs. In J. Strang and M. Gossop (eds) Heroin Addiction and Drug Policy: The British System. Oxford: Oxford University Press.
36. Strang, J., Sheridan, J. and Barber, N. (1996). Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. British Medical Journal, 313, 270-2.
37. Substance Misuse Advisory Service (1999). Commissioning Standards Drugs and Alcohol Treatment and Care, Health Advisory Service, London.
38. Task Force to Review Services for Drug Misusers (1996). Report of an Independent Review of Drug Treatment Services in England. London: Department of Health.